Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$23,318,509
-$1,375,553 QoQ
Shares Held
91,816
-9.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#677
of 4,676 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ANTIPODES PARTNERS Ltd holds $183,532,568 across 5 Drug Manufacturers - General names. JNJ ranks #2 (12.7% of the industry book) .
All Filings in JNJ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,318,509 | 91,816 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $24,694,062 | 101,023 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $24,173,001 | 116,806 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $28,918,659 | 155,963 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $23,222,888 | 152,032 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||